The monomer triethyleneglycoldimethacrylate (TEGDMA) is used as a diluent in many resinbased dental materials. It was previously shown in vitro that TEGDMA was released into the adjacent biophase from such materials during the first days after placement. In this study, the uptake, distribution, and excretion of 14C-TEGDMA applied via gastric, intradermal, and intravenous administration at dose levels well above those encountered in dental care were examined in vivo in guinea pigs and mice as a test of the hypothesis that TEGDMA reaches cytotoxic levels in mammalian tissues. 14C-TEGDMA was taken up rapidly from the stomach and small intestine after gastric administration in both species and was widely distributed in the body following administration by each route. Most 14C was excreted within one day as 14CO2. The peak equivalent TEGDMA levels in all mouse and guinea pig tissues examined were at least 1000-fold less than known toxic levels. The study therefore did not support the hypothesis.
INTRODUCTION
Desin-containing materials are used routinely in dental practice as direct filling materials, fissure sealing agents, bonding resins, and resin cements. Among the components of most bonding and restorative resins are (1) a primary resin, usually 2,2-bis-(4-(2-hydroxy-3-methacryloxypropoxy)phenyl)propane (Bis-GMA), and (2) triethyleneglycoldimethacrylate (TEGDMA), which is included to compensate for the high viscosity of the primary resin. Resin composites contain TEGDMA in amounts from 15 to 25%, while bonding resins contain TEGDMA in the range 30 to 55% (Nakabayashi and Takarada, 1992) .
Direct evidence of TEGDMA release from composite resins and fissure sealants into the biophase was provided by Tanaka et al. (1991) , Gerzina and Hume (1994) , Hamid and Hume (1997) , and Spahl et al. (1998) . TEGDMA can be expected to enter the body by two different routes after resin placement: via the saliva and gastrointestinal tract, plus (if the material is placed onto dentin) via the dentin and pulp . To tissue. Organs were immediately washed with 2 x 10 mL distilled H20, with the wash-water saved, and then the tissues were weighed and homogenized. Tissues were dissolved in tetraethylammoniumhydroxide (TEAH) (20%) in aqueous solution with Omni-Szintisol® (both from Merck, Darmstadt, Germany). 14C was determined with a liquid scintillation counter (2500 TR, Canberra-Packard, Dreieich, Germany). Data were presented as mean + standard error of the mean (SEM) of the administered dose. Statistical significance of differences between experimental groups was determined by means of the Bonferroni-Holm t test (Forst, 1985) . A second set of 16 guinea pigs was treated as described above, with the addition that each animal was kept in a closed chamber with controlled airflow. The exhaled air was captured during the 24-hour experimental period by flowing through 7 bottles, one behind the other, filled with 250 mL ice-cold 5 N NaOH (see Fig.) . 14C02 was captured as Na214C3, and the total 14C activity was determined.
Mice
The UCLA Committee on Animal Research, ensuring humane practices, approved the experiments. Twenty-three Balb-C, female mice, 6 to 7 weeks of age, were obtained from the UCLA animal colony and housed and fed routinely before the administration of 10 nanomoles (50 nCi total activity, 100 nmol/mL, 0.1 mL administered volume) 14C-TEGDMA by one of three routes: (1) by gastric tube, (2) into the tail vein, or (3) by intradermal injection beneath shoulder skin. Animals were killed by decapitation at various times after administration (see Tables 2 and 3) , and samples of blood and various tissues (see Tables) were taken Mouse-Gastric Administration 
Mouse-intravenous Administration

Mouse-Intradermal Administratn
Distribution and clearance of 14C were similar with this route of administration to that with gastric administration. Virtually all detectable 14C was cleared by one day after administration. The body-weight-adjusted dose of TEDGMA administered glucoeICogcicsis in kidncy cells ( Reichl ei zl. 999b ).
Brain levels of '4C following administiation by gastric tubc appeared to be markedly lower thall thosc of othel tissues, indicating that 4C-TEGDMA adminiiste-ed by that route did not cross the blood-brain barricr well. The mrajor route of uptake in humnans followinig filling placemnent is very likely to be via the saliva and stomacih. Followinlg intrave nous administiationi, brain levels were initially highier than those il blood and mlOSt otheIl tissucs, indicating selectiVe Liptake across the blood-braini barrier. I lowevcer, the peak concciti atioiis obsersved were far below any knowin toxic level. Therc is no knowin cquivaleClt to intravenious application inl cClinical usc.
AssuLiig that the metabolism and cleiaraice of TFGDMA in humans arc similar to thosc of guilnca pigs and ImlicC, it is therefoie extreilmely un1likely that T (GDMA ricleased fi-om restorative materials in hu1maIs could have systemic toxic effects.
